Laddar...

Treatment Outcomes and Tolerability Following Initiation of GLP-1 Receptor Agonists Among Type 2 Diabetes Patients in Primary Care Practices in Germany

BACKGROUND: The aim was to investigate real-world treatment outcomes and tolerability of GLP-1 receptor agonist (GLP-1RA) therapy in patients with type 2 diabetes in Germany. METHODS: Patients from 323 primary care practices who started any GLP-1RA therapy (89 Byetta, 108 Bydureon, 347 Victoza patie...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Diabetes Sci Technol
Huvudupphovsmän: Qiao, Qing, Johnsson, Kristina, Grandy, Susan, Kostev, Karel
Materialtyp: Artigo
Språk:Inglês
Publicerad: SAGE Publications 2016
Ämnen:
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5478013/
https://ncbi.nlm.nih.gov/pubmed/27470665
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1932296816661349
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!